KYTHERA Biopharmaceuticals to Present at Lazard Capital Markets 9th Annual Healthcare Conference

Before you go, we thought you'd like these...
Before you go close icon

KYTHERA Biopharmaceuticals to Present at Lazard Capital Markets 9th Annual Healthcare Conference

LOS ANGELES--(BUSINESS WIRE)-- KYTHERA Biopharmaceuticals, Inc. (NAS: KYTH) today announced that Keith Leonard, President and Chief Executive Officer, will present a corporate overview at the Lazard Capital Markets 9th Annual Healthcare Conference in New York City.


Event: Lazard Capital Markets 9th Annual Healthcare Conference, New York City
Date: Wednesday, November 14, 2012
Time: 9:00 a.m. ET

A live webcast will be available on the Company's website at www.kytherabiopharma.com under the Investors section. The presentation will be archived on the website and will be available for 14 days.

About KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's product candidate, ATX-101, is a potential first-in-class, injectable treatment currently in Phase III clinical development for the reduction of submental fat, which commonly presents as an undesirable "double chin." KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring. Find more information at http://www.kytherabiopharma.com.



KYTHERA Biopharmaceuticals, Inc.
Heather Rowe
Associate Director, Investor Relations
Tel: (818) 587- 4559
hrowe@kytherabiopharma.com

KEYWORDS:   United States  North America  California  New York

INDUSTRY KEYWORDS:

The article KYTHERA Biopharmaceuticals to Present at Lazard Capital Markets 9th Annual Healthcare Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners